HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Langer, B. G. Articles by Bell, W. R. Search for Related Content PubMed PubMed Citation Articles by Langer, B. G. Articles by Bell, W. R. Social Bookmarking                      What's this?

J. Biol. Chem., Vol. 263, Issue 29, 15056-15063, Oct, 1988

Deglycosylation of fibrinogen accelerates polymerization and increases lateral aggregation of fibrin fibers

BG Langer, JW Weisel, PA Dinauer, C Nagaswami and WR Bell
Department of Medicine, Johns Hopkins University, Baltimore, Maryland 21205.

Fibrinogen, the major structural precursor of blood clots, was deglycosylated by peptide-N-(N-acetyl-beta-glucosaminyl)asparagine amidase without denaturation of the polypeptide chains. Deglycosylated fibrinogen behaved normally in clinical coagulation assays, although it is less soluble than normal fibrinogen. However, the turbidity of clots formed from deglycosylated fibrinogen always rose faster and higher than that of clots from normal fibrinogen. Scanning and transmission electron microscopy demonstrated that fibrin made from clots of deglycosylated fibrinogen consisted of thicker, less-branched fiber bundles in a more porous network. Moreover, the degree of lateral aggregation was directly related to clot turbidity and inversely related to branching. Deglycosylation promoted turbidity development, lateral aggregation, and porosity of clots under all conditions tested. All other steps in the coagulation pathways appeared to be unaffected by the absence of carbohydrate. These results suggest that carbohydrate constitutively affects the behavior of deglycosylated fibrinogens by 1) contributing a repulsive force that promotes fibrinogen solubility and limits fibrin assembly and 2) sensitizing fibrin to conditions that influence assembly and clot structure.
CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				A. A. Amelot, M. Tagzirt, G. Ducouret, R. L. Kuen, and B. F. Le Bonniec Platelet Factor 4 (CXCL4) Seals Blood Clots by Altering the Structure of Fibrin J. Biol. Chem., January 5, 2007; 282(1): 710 - 720. [Abstract] [Full Text] [PDF]

				M. A. Keller, J. Martinez, T. C. Baradet, C. Nagaswami, I. N. Chernysh, M. K. Borowski, S. Surrey, and J. W. Weisel Fibrinogen Philadelphia, a hypodysfibrinogenemia characterized by abnormal polymerization and fibrinogen hypercatabolism due to {gamma} S378P mutation Blood, April 15, 2005; 105(8): 3162 - 3168. [Abstract] [Full Text] [PDF]

				J. L. Moen, O. V. Gorkun, J. W. Weisel, and S. T. Lord Recombinant B{beta}Arg14His fibrinogen implies participation of N-terminus of B{beta} chain in desA fibrin polymerization Blood, October 1, 2003; 102(7): 2466 - 2471. [Abstract] [Full Text] [PDF]

				C. A. Ufret-Vincenty, D. J. Baro, and L. F. Santana Differential contribution of sialic acid to the function of repolarizing K+ currents in ventricular myocytes Am J Physiol Cell Physiol, August 1, 2001; 281(2): C464 - C474. [Abstract] [Full Text] [PDF]

				T. Sugo, C. Nakamikawa, N. Yoshida, K. Niwa, M. Sameshima, J. Mimuro, J. W. Weisel, A. Nagita, and M. Matsuda End-linked homodimers in fibrinogen Osaka VI with a Bbeta -chain extension lead to fragile clot structure Blood, December 1, 2000; 96(12): 3779 - 3785. [Abstract] [Full Text] [PDF]

				T. Sugo, C. Nakamikawa, H. Takano, J. Mimuro, S.-i. Yamaguchi, M. W. Mosesson, D. A. Meh, J. P. DiOrio, N. Takahashi, H. Takahashi, et al. Fibrinogen Niigata With Impaired Fibrin Assembly: An Inherited Dysfibrinogen With a Bbeta Asn-160 to Ser Substitution Associated With Extra Glycosylation at Bbeta Asn-158 Blood, December 1, 1999; 94(11): 3806 - 3813. [Abstract] [Full Text] [PDF]

				Y. Veklich, C. W. Francis, J. White, and J. W. Weisel Structural Studies of Fibrinolysis by Electron Microscopy Blood, December 15, 1998; 92(12): 4721 - 4729. [Abstract] [Full Text] [PDF]

				H. C.F. Cote, S. T. Lord, and K. P. Pratt gamma -Chain Dysfibrinogenemias: Molecular Structure-Function Relationships of Naturally Occurring Mutations in the gamma  Chain of Human Fibrinogen Blood, October 1, 1998; 92(7): 2195 - 2212. [Full Text] [PDF]

				O. V. Gorkun, Y. I. Veklich, J. W. Weisel, and S. T. Lord The Conversion of Fibrinogen to Fibrin: Recombinant Fibrinogen Typifies Plasma Fibrinogen Blood, June 15, 1997; 89(12): 4407 - 4414. [Abstract] [Full Text] [PDF]

				J. L. Woodhead, C. Nagaswami, M. Matsuda, C. L. Arocha-Piņango, and J. W. Weisel The Ultrastructure of Fibrinogen Caracas II Molecules, Fibers, and Clots J. Biol. Chem., March 1, 1996; 271(9): 4946 - 4953. [Abstract] [Full Text] [PDF]

				J. L. Mullin, O. V. Gorkun, C. G. Binnie, and S. T. Lord Recombinant Fibrinogen Studies Reveal That Thrombin Specificity Dictates Order of Fibrinopeptide Release J. Biol. Chem., August 11, 2000; 275(33): 25239 - 25246. [Abstract] [Full Text] [PDF]